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ABSTRACT

Childhood migraine is a prevalent disorder seen in
pediatric practice.

Preliminary uncontrolled reports

evaluating skin temperature biofeedback with autogenic
training have suggested that it may be a useful interven
tion for childhood migraine.

The present study used a

controlled group outcome design to further evaluate the
effectiveness of skin temperature feedback with autogenic
training and home practice.
Subjects were 28 children,
14 females.

ages 7 to 16, 14 males and

After receiving a physician's diagnosis of

migraine a second diagnosis of migraine was made by the
experimenter.
intensity,

Children were matched by baseline headache

sex and age and then randomly assigned to either

a waiting-list control or treatment group.
Six dependent measures of headache activity were o b 
tained from weekly headache records that the child and
parents kept during baseline,

treatment and follow-up.

Assessment of ability to increase skin temperature without
feedback was made at pre- and post-treatment sessions.
The waiting-list control group attended 2 attention
placebo sessions during the baseline period and one at the
end of treatment.

The treatment group participated in two
vii

pre-treatment measurement sessions and 10 treatment sessions
with home practice.

Nine sessions included analogue skin

temperature feedback and self-control phases.

The tenth

consisted of self-control only.
Results of a 2x3 analysis of variance with one repeated
measure found the treated group was improved significantly
on headache index,

frequency,

duration, highest headache

intensity rating and average peak headache intensity rating
at the end of treatment as compared to the waiting-list
control group.

At the one-month follow-up these headache

variables were still significantly improved for the treated
group, and their medication index was also significantly
reduced as compared to the waiting-list control group.
Analyses of the skin temperature data showed the
treated group significantly increased skin temperature w i t h 
out feedback at the end of treatment as compared to pre
treatment performance, but scores were not significantly
different from the waiting-list control group's scores.
The study is the first controlled experimental demon
stration that skin temperature biofeedback with autogenic
training and home practice is an effective treatment for
childhood migraine.

INTRODUCTION

Migraine headaches are one of the most common dis
orders seen in pediatric practice, with an incidence of
approximately 50 cases per 1000 children or 4-5 percent
incidence of children between ages 7 and 15 years
1967; Brown,

1977).

(Bille,

The prevalence of migraine increases

with age and is rare under 2 years of age.

Before puberty,

the prevalence of migraine is equivalent for males and
females.

After puberty,

the ratio changes with more women

reported than men as migraneurs
Thompson,

(Waters & O'Connor,

1975;

1980).

Williamson (1981) has noted that although migraine
headaches have generally been considered a clinical problem
of interest to the medical profession,

in recent years more

physicians and psychologists think of most headaches to be
of psychological origin.

Behaviorally oriented psycholo

gists have begun to successfully apply behavioral principles
to the assessment and treatment of headaches.

They have

also contributed theories concerning the development and
maintenance of migraine headache.

There is an extensive

literature concerning etiology and treatment of headaches
with a d u l t s , especially migr a n e u r s .

However there are

relatively few studies of headaches in children (Brown,

1977; Thompson,

1980).

Thus much of the information on

headache symptomology, pathophysiology and treatment pr e 
sented in this paper is based on research with adults.
Clinical Symptomology
Migraine headache,

as proposed by the Ad Hoc Committee

of the classification of headaches
tic categories,

(1962), has two diagnos

classic and common.

In the classic form

the headache consists of three phases.

During the first

phase, prodromal symptoms are usually reported.

Prodromal

symptoms usually occur between 10 and 30 minutes before
onset of the headache.
flashing lights,

Common prodromes are scotomata,

fortification spectra, abdominal pain,

vertigo and parathesias of the face or hands
1981; Prensky & Sommer,

1979).

(Williamson,

Many nonspecific changes

may occur in the prodromal phase.

In children,

increases in bedwetting, nightmares,

somnabulism and sleep

disturbances may precede the headache (Thompson,
During the second phase,

specifically,

1980).

the migraine headache occurs.

The headache phase is characterized by the onset of throb
bing or pulsating, unilateral pain.
often in the temporal,
cranial regions.

orbital,

The pain occurs most

supra-orbital or occipital

Head pain is usually accompanied by

nausea, photophobia,

and constipation or diarrhea.

Local

edema often results around the affected area of the head.
Edema exacerbates the pain and may leave the area sensitive
after the headache has ended.

In the final phase, p ost

headache, most children report a feeling of exhaustion.
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Some are very talkative and occasionally euphoric.

Those

who retain fluid during an attack may experience polyuria
(Thompson,

1980).

Common migraine headache is similar to classic migraine
except pain is not well localized and often has a bilateral
location.

Prodromal symptoms are not experienced and head

aches tend to be somewhat longer (Adams, Feuerstein &
Fowler,

1980).

Congden and Forsythe

(1977) have noted that no one

definition of childhood migraine has gained universal accept
ance.

Prensky and Sommer (1979) have enumerated criteria

that they believe are suitable for diagnosis in children.
The criteria suggested by Prensky and Sommer are often used
for studies of children with migraine headaches
Forsythe,

1979; Jay & Tomasi,

1981).

(Congden &

Their criteria are

similar to those suggested by the Ad Hoc Committee on the
Classification of Headache (1962).

Prensky and Sommer

specify that the headaches must be separated by symptomfree periods and insist that at least three of the following
six symptoms occur:
pain or hemicrania,
5) visual,

1) nausea and vomiting,
3) pulsating pain,

2) unilateral

4) relief after rest,

sensory or motor prodromes and 6) history of

migraine in immediate family.

Using the six symptoms as

criteria, both common and classic migraine types are in
cluded.

Prensky and Sommer's diagnostic criteria were

used in defining the subject population for the present
st u d y .

The frequency of migraine occurrence may vary widely
from individual to individual, but at least one episode
per month has often been reported for children (Bille,
1967).

There is evidence that migraine headache episodes

are generally shorter in children, usually lasting an hour
or more, but rarely longer than 12 hours
H a c k z e l l , 1949; Bille,

(Vahlquist &

1967).
Pathophysiology
4

Neurological, biochemical and vascular mechanisms
have been implicated in the pathophysiology of migraine
headaches.

It appears that migraine patients may be charac

terized by greater reactivity of autonomic r e sponses, espe
cially with increased cephalic vasoactivity.

A variety of

biochemical mechanisms have been proposed to explain the
increased vasoactivity that has been demonstrated in cere
bral and systemic blood vessels.

No one theory explains

all the phenomena of migraine, but considerable advances
have been made during the past 20 years.

Research has been

difficult in the area of migraine because it is a transient
functional disorder that leaves no permanent structural
change after the headache.

Furthermore, animal experimen

tation is not readily applicable to the problem (Diamond &
Dalessio,

1978; Walshe,

1969).

Neurological Pain Pathways
Neurological pain pathways for pain sensitive areas of
the head have been established (Diamond & Dalessio,
Structures included are the arteries, muscles,

1978).

scalp and

skin of the head.

For pain in the frontal,

temporal or

parietal a r e a s , the trigeminal nerve is thought to be in
volved.

The glossopharnyngeal and vagal nerves are involved

in pain of the occipital region.
Hormonal Theories
Migraine in females frequently begins at menarche,
improves during pregnancy,

is aggravated by oral contracep

tives and disappears with menopause (Whitty, Hockady &
Whitty,

1966).

ing adolescence.

In males, migraine frequently improves dur
Observations such as these imply involve

ment of sexual hormones,

e.g., estrogen, progesterone and

perhaps prolactin (Wainscott, ref. note 1).

Brown (1977)

suggests normal hormonal changes influence the occurrence
of headaches in the generally predisposed individual.
Dennerstein,

Toby, Burrows and Hyman (1970) report migraine

frequently increases with decreasing serum estrogen levels.
Graham (1981) hypotheses that histamine as well as anti
histamines are increased as a result of hormones during
pregnancy.

And alternative hypothesis to a direct effect

is offered by Stein (1980) who suggests that hormones may
act indirectly influencing the metabolism of vasodilating
substances such as serotonin.

There are several theories

describing the role hormones may play in causing, predis
posing or diminishing migraine.
adequately researched,

No one theory has been

thus it is difficult to draw conclu

sions on the biochemical influence hormones have on the
production of migraine headaches.

Biochemical Theories
Vasoactive amines have been implicated in the patho
genesis of migraine

(Thompson,

1980).

Some patients report

the onset of headache after ingestion of cheese or chocolate,
suggesting an effect of tyramine and plenylethylamine,
respectively,

on blood vessels sensitive to these substances

(Harrington & Harper,

1967).

Experimental studies in which

migraine patients have been given tyramine have produced
conflicting results

(Brown,

1977).

Another biochemical theory suggests that changes in
platelet aggregation and the blood clotting systems play a
role in the migraine attack (Appenzeller, 1969).

Platelet

aggregation is increased during the prodrome and decreased
during the headache.

Serotonin, a vasoconstrictor,

induces

platelet aggregation and platelet serotonin is rapidly metabo
lized, resulting in vasodilation of scalp vessels secondary
to withdrawal from its vasotonic effects
& Hinterberger, 1969; Freidman,

1978).

(Lance, Anthony,
One problem with

this theory is that serotonin could be secondary to changes
in platelet aggregation, because the serotonin that is r e 
leased is already contained in the platelets
Dalessio,

1978).

(Diamond &

The serotonin hypothesis also fails to

explain the unilaterality and periodicity of migraine.
There is limited experimental support for this theory.
Studies on the action of serotonin on intra- and extracranial blood flow in humans and animal research have been
conflictual

(Adams et a l ., 1980).

Two studies using migraine

patients found that intra-cranial injection of serotonin
had little effect on the calibar of intra-cranial arteries
(Lance, Anthony 6c Gonski,

1967).

Lance et al. did find

vasoconstriction of the external carotid with injections
of serotonin.

Studies investigating the effects of intra

carotid injection of serotonin with animals reported results
conflicting with the Lance et a l . studies.
studies,

In the animal

constriction of both intra- and extra-cranial

arteries resulted with injection of serotonin (Welsh, H a s k i ,
& Meyer,

1973;

Welsh,

Spira, Knowles, 6c Lance,

1974).

Hemodynamic Theories
Hemodynamic studies support Wolff's
theory of migraine.

Wolff describes three phases of migraine

characterized by vascular changes.
headache,
occurs.

(1963) classic

In the first phase, p r e 

constriction of intra- and extra-cranial arteries
This reduction of blood supply was thought to

cause prodromal symptoms.

Most hemodynamic studies

have reported that during the pre-headache phase,
cranial and extra-cranial vasoconstriction occurs.

intra
Skinhoj

(1973) reported approximately 20-50% reduction of intra
cranial blood flow that is usually most pronounced in the
cortical areas associated with prodromal symptoms of classic
migraine patients.

Presently, medical researchers have not

firmly established the reasons for the absence of prodromes
in common m i g r a i n e .

Recent evidence indicates common and

classical migraine headache may differ due to degree of v a s o 
spasm or differing metabolic demands of the brain (O'Brien,
1971).

Wolff contended that the headache phase was caused by
vasodilation of the internal and external carotids.

Head

ache pain results from increased tension within or about
pain sensitive arterial walls due to the increased blood
flow after vasodilation.

Hemodynamic studies have found

small increases of intra-cranial blood flow and profound
extra-cranial vasodilation during the headache phase
(Skinhoj, 1973).
During the post-headache phase the vascular systems,
according to Wolff, return to preheadache conditions.
Edmeads

(1977) found that although blood supply did decreas

during the preheadache phase and increased during the head
ache phase, vascular changes did not correlate precisely
with occurrence of symptoms features.

Diamond and Delassio

(1978) suggest Wolff's theory gives a good description of
vascular changes but is inadequate in explaining the
etiology of migraine.
Unified Theory of Migraine
Biochemical, neurological and vascular theories to
date do not give a comprehensive explanation of the phenome
non of common and classical migraine.

What is important to

note is extra-cranial vasodilation does not invariably p r o 
duce headache.

Thus an adequate theory must be able to

explain the simultaneous vascular and humoral changes that
result in a sterile inflamation and a unilateral vasospasm
of the intra-cranial and extra-cranial arteries.

Diamond

and Dalessio (1978) have formulated a unified theory of

migraine which presently is the best integrated theory of
the pathophysiology of migraine.
Diamond and Dalessio contend that migraine must be
understood in terms of three parallel response systems,
vascular, biochemical and subjective/behavioral.

Unlike

Wolff and others they discuss only two phases, pre-headache
and h e a d a c h e .
Diamond and Dalessio adopt Oleson's

(1972) theory of

cerebral blood supply control mechanisms to explain the
vascular changes during migraine attacks.

Oleson proposed

two vascular systems which control blood flow within the
cerebrum.

The first system,

the "innervated cerebral

vascular system" consists of pial and large arteries at the
base of the brain.
system.

Adrenergic nerve fibers innervate this

The "innervated cerebral vascular system” is

responsive to external or non-local influences.

Diamond

and Dalessio suggest that an external event, particularly
a stressful one,

can cause vasoconstriction of the arteries

of this system.
The second system is called the "non-innervated cere
bral system."

It consists of parenchymal vessels which

mostly respond to local metabolic needs of brain tissues.
This second system is unresponsive to external events and
non-local influences because it is not innervated by
adrenergic nerve fi b e r s .
Diamond and Dalessio postulate that during the p r e 
headache phase,

the innervated cerebral vascular system
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constricts creating a reduction in blood flow resulting in
hypoxia and cerebral acidosis.

Classic migraine patients

may experience focal neurological symptoms or prodromes at
the subjective/behavioral level.

In response to these

vascular changes the non-innervated cerebral vascular system
will vasodilate to meet the metabolic needs of local brain
tissue.

The large extra-cranial arteries will also become

dilated to increase the intra-cranial blood flow if susi

tained intracranial vasodilation is required.

Wolff (1963)

and Dalessio (1972) suggest that a defective neurogenic
mechanism,

an abnormal extracranial vasomotor response, may

be characteristic of individuals susceptible to migraine.
This "over-reaction" to intra-cranial vasoconstriction r e 
sults in excessive vasodilation of extra-cranial arteries.
Massive vasodilation of extra-cranial arteries results in
release of histamine and peptide kinins as well as mechani
cal stimulation of free nerve endings.
phase,

During the headache

extreme vasodilation and liberation of histamine and

peptide kinins result in sterile inflamation and local edema
and the behavioral experience of pulsating pain.
This theory stresses the dysregulation of cephalic
blood flow rather than serotonin, histamine and other v a s o 
active substances.

Diamond and Dalessio's position is quite

a contrast to other theories discussed such as A ppenzeller1s
(1969) and Wolff's

(1963).

No one theory is supported more

than the other by research in the field.

However, Diamond

and Dalessio present the best integration of existing data

pertaining to migraine pathophysiology.

What is important

about the unified theory of migraine is that although they
do not elaborate on environmental, behavioral and cognitive
factors, Diamond and Dalessio do recognize that these fac
tors may play a role in the development of migraine.
Treatment of Migraine Headache
Adult Studies
Although this particular study was concerned with
children who have migraine h e a daches, a brief review of
treatment approaches for adult migraineurs is in order,
especially since treatment research concerning children is
scant.

Traditional medical procedures can be classified

as abortive, prophylactic, palliative or surgical.

Abor

tive and prophylactic treatments can be effective in al
leviating migraine headaches.

However,

abortive or

prophylactic medication may result in serious side effects.
For instance, with an abortive medication such as ergotamine
tartrate, nausea, vomiting,
ing may result.

diarrhea,

drowsiness and cramp

Development of tolerance to medications

used as a preventive measure,

e.g.,

ergotamine and m e t h y -

sergide, may occur and create withdrawal symptoms,
& Falkowski,

1973).

Palliative treatment,

(Lucas

usually narcotic

medications, may be helpful but varies on an individual
basis and abuse of narcotics is possible.

Surgical inter

ventions have not proven to be adequately beneficial to
warrant permanent structural damage (Adams et a l ., 1980).
Because of the harmful short and long term side-effects
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and variable success of medical approaches, behavior therapy
has developed a variety of behavioral interventions for the
treatment of migraine h e a d a c h e s .
Four behavioral interventions have been found to be
more effective than no treatment control conditions.

These

treatment procedures are skin temperature biofeedback with
autogenic training,

relaxation training,

cephalic vasomotor

biofeedback and behavioral self-management.

No one treat

ment has been shown to be more effective than the o t h e r s .
Controlled outcome studies have reported that between 407>
and 1007o of adult patients have improved after treatment.
Skin temperature biofeedback with autogenic training.
Skin temperature biofeedback with autogenic training was
one of the first behavioral interventions to be studied.
Skin temperature biofeedback involves instructing the p a 
tients to raise their skin temperature, usually of their
index finger or hand.

Feedback can be in the form of visual

or auditory signals, which change as a function of changes
in skin temperature.

Within each session, after a p r e 

determined time, feedback is often withheld and the patient
is asked to continue to raise his or her skin temperature.
This treatment phase is usually called self-control.

Skin

temperature feedback is usually combined with autogenic
training.

This component is used to help patients 'warm

their hands and relax further.

Autogenic training consists of

having the patient imagine various sensations and instructing
how to relax muscles.

For instance,

the patient is instructed

to imagine his or her hand becoming heavy and warm.

Once

the patient achieves the feeling of warmth and heaviness,
he or she then concentrates on breathing and heart rate,
imagining that heart rate and breathing are regular and
calm.
Several early reports indicated that skin temperature
feedback was effective with migraine headaches
Green, 5c Walters,

1972; Mitch, McGardy, 6c Iannone,

Solback 6c Sargent,
Dalessio,

(Sargent,

1978).

1977; Sovac, Kunzel,

1976;

Sternback, 6c

Early studies were promising but outcome

data were subjective and they lacked experimental control
groups.

More recently,

a controlled group outcome study

with one year follow-up data has been reported (Blanchard,
Theobald, Williamson,
Blanchard, Williamson,

Silver, 6c Brown,

1978;

Theobald, 6c Brown,

Silver,

1979) .

Skin

temperature biofeedback with autogenic training was found
to be superior to a waiting-list control that monitored
headache activity.

In addition, at the end of treatment

54% of the subjects were either headache free or much im
proved (as defined by 50% reduction of headache frequency
or intensity).

At a three-month follow-up success was 40%

and this improvement was maintained at one year follow-up.
Several studies using skin temperature biofeedback
without autogenic training have shown skin temperature
feedback to reduce headache activity (Johnson 6c Turin,
Turin 6c Johnson,
1976).

1975;

1976; Wickramasekera, 1973; Reading 6c Mohr,

One controlled group outcome study by Mullinix,
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Norton, Hack,

and Fishman (1978) compared one group receiv

ing true skin temperature feedback to one receiving false
skin temperature feedback.

The true feedback group increased

temperature better than the false feedback group, but there
were no differences between the groups on headache m e a s u r e s .
Headache activity for both groups was decreased.

Thus it is

not clear whether improvements were due to experimental or
placebo effects

(Williamson,

1981).

Psychophysiological explanations for the effectiveness
of skin temperature biofeedback have been of two k i n d s .
Sargent et a l . (1972,

1973) first explained the phenomenon

in terms of modifying peripheral and cephalic vasomotor
responses.

Initially he thought that as peripheral vas o 

dilation from hand warming occurred that cephalic v aso
constriction would occur.

Recent studies do not support

Sargent's hemodynamic theory (Price & T u r s k y , 1976; Sovack
et a l . , 1978).

Results of recent skin temperature feedback

studies showed for most cases cephalic vasodilation occurred
with peripheral vasodilation during hand warming.

However,

for some of the subjects in the Sovack et a l . study, cephalic
vasoconstriction occurred.

Sovack et a l . hypothesized that

skin temperature feedback was effective because it produced
a general decrease of sympathetic arousal.
Cinciripini, Williamson and Epstein (1981) have p r o 
vided an alternate explanation in which they hypothesize
skin temperature training procedures produce effects counter
acting the intra-cranial vasoconstriction of the preheadache

phase.

Counteracting the initial vasoconstriction would

reduce the vasodilation of the rebound effect of the hea d 
ache phase.

Support for either of the two theories of the

physiological mechanisms underlying the effectiveness of
skin temperature feedback have been minimal.

Further r e 

search is warranted before either of these models can be
accepted or rejected.
Relaxation training.

Relaxation training has been

used for the treatment of migraine headache in six studies
(Lutker,

1971;

Warner 5c Lance,

Hay & Madden,
1975;

Blanchard et al.,

1971;

Paulley & Haskell,

Benson, Klemchuk, 6c Graham,

1978).

1975;

1974;

With the exception of Benson et al.'s

study, shortened versions of Jacobson's (1938) progressive relaxa
tion procedure have been employed.

Exercises consist of

instructing the patient to tighten then relax various
muscle groups of the body.

Between exercises,

suggestions

of heaviness, warmth and looseness are given to the patient.
As patients become more able to relax their muscles, muscle
groups become combined and the number of muscle groups is
reduced.

As treatment comes to an end, relaxation by recall

for use in the natural environment is faded in.

Patients

are often given tapes of the relaxation procedure to assist
in practice at home.
Five of the six studies mentioned lack proper experi
mental control groups and objective outcome data.

The

sixth (Blanchard et a l ., 1 9 7 8 ) was a controlled group out
come study which evaluated progressive muscle relaxation

and compared it to autogenic feedback and a waiting-list
control group.

Blanchard et a l . found relaxation training

to be significantly more effective than no treatment and
equivalent in effectiveness to autogenic feedback.

At the

end of treatment 88% of the subjects were much improved or
headache free.

At a 3-month follow-up the success rate

was 567o and treatment gains were maintained at one-year
follow-up (Silver et al.,

1979).

At this time, relaxation

training appears to be an effective treatment for migraine
headache.

Blanchard et al.'s study also indicates that

relaxation training and skin temperature feedback with
autogenic training have similar effects on headache activity
Silver and Blanchard (1978) suggest that these interventions
may be operating via the same psychophysiological mechanisms
reduced sympathetic arousal.
Cephalic vasomotor biofeedback.

Cephalic vasomotor

biofeedback for training in vasoconstriction of extracranial arteries would seem to be a reasonable intervention
since migraine headache is caused by vasodilation of extracranial arteries and vasoconstrictive medication such as
ergotamine tartrate can alleviate head pain.

Studies of

cephalic vasomotor biofeedback have used similar methodology
For the majority of the studies only cephalic vasomotor
feedback (CVM) was given.

In order to record CVM, sensors

for the vasomotor response are usually placed on the right
zygomaticofacial branch of the superficial temporal artery.
A few studies have used electromygraphic

(EMG) feedback

along with CVM feedback or have given sessions of EMG feed
back interspersed between sessions of CVM feedback.
feedback gives feedback of local muscle tension.

EMG

The

frontalis muscle region is usually the site used for EMG
feedback.

During a feedback session the patient is pr o 

vided with contingent binary feedback.
Six studies examining the effects of cephalic vasomotor
biofeedback have reported success with migraine headaches
(Feuerstein, Adams, & Beiman,
Adams,

1976; Sturgis, Tollison, 6t

1978; Feuerstein 6c Adams,

Bild 6c Adams,

1980;

1977; Friar 6c Beatty,

Cohen, McArthur, 6c Rickies,

1976;

1980).

Three of the studies were multiple-baseline designs and two
were controlled group outcome studies.

The first controlled

group outcome study compared a placebo condition to cephalic
vasomotor biofeedback (Friar 6c Beatty,

1976) .

Results found

cephalic vasomotor biofeedback to be superior to the placebo
conditions.

The second controlled group outcome study com

pared cephalic vasomotor response feedback, EMG biofeedback
and a waiting-list control (Bild 6c Adams,

1980).

EMG b i o 

feedback reduced headache frequency and duration by 50% for
at least 50% of the treated subjects, which was not signifi
cantly different from the control group.

Cephalic vasomotor

biofeedback was more effective than the control procedure
and was successful in reducing headache frequency and dura
tion by at least 50% for 86% of the treated subjects.
Cephalic vasomotor feedback produced greater changes than
EMG feedback but these differences were not significant.

Cohen et a l . (1980) compared four biofeedback treatments
for headache.

The four feedback modalities were forehead

skin temperature,

frontalis EMG, alpha waves and vasomotor

response of the temporal scalp a r t eries.

A group compari

son found that all patients demonstrated a significant
reduction in number of headaches per week with no change
in intensity,

disability or length of headaches.

Cephalic

vasomotor feedback was as effective as skin temperature,
EMG and alpha wave feedback.
Cephalic vasomotor biofeedback,
controlled group studies,

as evidenced from the

appears to be a viable and more

effective treatment for migraine headache patients than no
treatment.

Also cephalic vasomotor feedback is as success

ful as skin temperature feedback, EMG feedback and relaxa
tion training in the treatment of migraine hea d a c h e s .
It is interesting to note relaxation training and skin
temperature feedback p rocedures, both thought to produce
cephalic vasodilation, have equal success rates to cephalic
vasomotor feedback which produces the opposite effect of
vasoconstriction.

It is possible that psychophysiological

effects of cephalic vasomotor feedback are different from
relaxation training and skin temperature feedback.

Cephalic

vasomotor feedback may be effective in aborting or reducing
head pain when vasodilation o c c u r s .
and skin temperature feedback,

Relaxation training

on the other hand, may be

effective in reducing or aborting head pain by vasodilation
during the preheadache phase or by reducing general sympathe
tic arousal (Williamson,

1981).
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Cohen et al.

(1980)

feedback procedures,

in their comparison of four b i o 

including skin temperature feedback

and cephalic vasomotor feedback recorded physiological data
throughout the study.

Psychophysiological changes noted

were consistently small and unrelated to headache outcome.
Cohen et a l . conclude the effectiveness of the biofeedback
procedures were similar and they attribute the success to
a nonspecific one such as a relaxation phenomenon or cogni
tive restructuring of perceived self-control.
vasomotor feedback,

Thus cephalic

although seemingly producing a potent

vasoconstriction response effect, may be successful because
of its relaxation effect.
In summary, biofeedback and relaxation approaches to
migraine headaches appear to be equally efficacious with
adult migraine subjects.

Although only one or two controlled

group outcome studies have been reported for each interven
tion, results are promising for behavioral approaches to
migraine.

Replication of the controlled group outcome

studies is in order.

Component analysis of treatment inter

ventions would be informative,
feedback.

especially for autogenic

Further studies including placebo conditions and

false-feedback versus true-feedback needs to be conducted.
Physiological mechanisms influenced by feedback and relaxa
tion procedures are not well understood and basic research
on this issue is n e e d e d .
Self-management p r ocedures.

A fourth type of inter

vention that has been reported to be successful with migraine

patients is a comprehensive behavioral self-management
package (Mitchell & Mitchell,

1971).

Mitchell and White

(1977) used a dismantling design to assess the contributions
of various elements of the program which included self
monitoring of headache activity, relaxation,

self-

desensitization and self-management skills,

such as

thought-stopping and assertion training.

Self-monitoring

of headache activity had no effect on headache pain.

Re

laxation training and self-desensitization resulted in 50%
reduction of headache frequency with 70.4% of the subjects
so improved.

The addition of other self-management skills

produced even further reduction of headache activity for
100% of the treated subjects.
at a 3-month follow-up.

Improvements were maintained

The results of the self-management

program are better than those reported for other behavioral
interventions.

More research is needed in this area,

cluding replication and component analysis,

in

as well as com

parison to biofeedback techniques and relaxation alone.
Child Studies
Traditional treatment of children with migraine h e a d 
aches has followed one of two approaches.

The first and

most common treatment method is via drugs as a prophylactic,
abortive or palliative agent.

Brown (1977) has recommended

that drug therapy on a regular basis should be reserved for
those children who have frequent and severe attacks that
seriously interfere with normal functioning.

For nausea

or vomiting, prochlopezine (Stemetil) has been found to be
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helpful.

For severe migraine, preparations of ergotamine

tartrate (Cafergot, Migril)
headache.

are often used to abort the

Mild to moderate headaches can usually be

managed by having the child rest and take aspirin or
acetaminopen.

Friedman (1967) has stressed that drug

treatment of headache symptoms requires the utmost prudence,
particularly for children, because their response to drugs
is predictable only to a limited extent from adult experi
ence.

He emphasizes not only the possible toxic effects

from continuous use of medications but also adverse psycho
logical consequences of emphasizing only the alleviation of
migraine headache s y m ptoms.

Drug therapy may provide

significant alleviation of migraine headaches in some cases
but because of side effects, particularly in long-term use,
there is a need for other nonpharmacological treatments of
migraine.
The second traditional type of treatment for childhood
migraine involves play techniques.

These techniques are

usually based upon psychodynamic theories.

Although play

techniques have been reported to be successful for alleviat
ing headaches

(Adams,

1967), no objective or systematic

studies have been reported.

Therefore,

the development of

alternate, nonpharmacological interventions is needed for
such a common,

long-lasting and often debilitating disorder

as migraines in children.
As discussed in the previous section,

several behavioral

interventions have been found to alleviate migraine headaches

in adults.

It seems reasonable to suggest that these same

interventions may be successful for childhood migraine.
Only a few behavioral interventions,
biofeedback,

i.e., skin temperature

cephalic vasomotor biofeedback and contingency

management, have been studied with children migra n e u r s .
Four studies have been reported using skin temperature
biofeedback with autogenic training and home practice.
Pepper and Grossman (Ref. note 2) reported upon the success
ful treatment of two girls, ages 9 and 13, with migraine
headaches.

Their study lacked proper experimental control

and objective outcome data,
intervention may

but results indicated that this

be useful. An uncontrolled group study

(Diamond 5c Franklin,

1975) tested the efficacy of skin

temperature and EMG biofeedback with autogenic training and
home practice with children who had common migraine.
a 30-month period,

32 children,

During

ages 9 through 18, were

treated and results indicated a decrease in frequency and
severity of migraines in 26 of the cases.

Three children

experienced either a decrease in frequency or severity of
headache but not both,

2 children showed no response,

one was "lost to

follow-up" (p.191).

available and no

systematic recording of headache variables

or follow-up data were reported.

No control

and

group was

Andrasik, Blanchard,

Edlund and Rosenblum (in press) presented two case studies
of children migraneurs using skin temperature feedback and
autogenic training.
headache activity

On visual inspection of graphs of

(intensity, frequency and headache free

days) improvements are noticeable.

Both headache sufferers

achieved improvement rates of 57% at follow-up on all
measures of headache activity.
L a b b e 1 and Williamson (Ref. note 3) utilized a
multiple-baseline across subjects design to evaluate
temperature biofeedback with autogenic training for the
treatment of migraine headache in three children,
(age 9) and two boys

(ages 12 and 13).

one girl

Baseline recording

of headache for subjects 1, 2 and 3 were taken for 6, 7
and 8 weeks respectively.

Each child participated in ten

treatment sessions which consisted of skin temperature
biofeedback and self-control of skin temperature.

Mean

skin temperature across sessions showed that all three sub
jects increased their finger temperature by an average of
.57° Celsius during feedback and self-control phases.
report of headache frequency duration,

Self-

intensity and dosage

of medication were recorded throughout the study.

Results

indicated that the average headache rating for the week
(headache index) was reduced after treatment.
lar analyses of frequency,

intensity,

More molecu

duration and medica

tion indices found that these variables were also reduced
after treatment and were maintained during follow-up at one
month.

Thus four studies using either single case or single

group experimental methodology reported using skin tempera
ture biofeedback for the treatment of childhood migraine.
While these findings are promising,

they suggest controlled

group outcome research with this intervention is warranted

in order to rigorously evaluate its efficacy.
Ramsden,

Friedman and Williamson (Ref. note 4)

applied contingency management procedures in the treatment
of a 6-year-old girl who had been diagnosed as having
migraine headaches.

Careful behavioral assessment suggested

this case was best conceptualized as an operant pain case
since headache reports occurred under only a few stimulus
conditions,

e.g. work situations, and consistently produced

sympathy and relief from responsibilities.

A multiple-

baseline across settings design was employed,
school and then at home.

first in

A substantial reduction in head

pain reports over the 18 weeks of the study was found and
the effects of the contingency management procedure were
maintained at a 10-month follow-up.

Ramsden et al.'s study

is interesting because it suggests that environmental con
sequences may be an important factor in headache reports,
especially for children.
Only one case study using cephalic vasomotor biofeedback in the treatment of migraine in an adolescent has been
reported.

Feuerstein and Adams

(1977) reported 4 case

studies using EMG feedback and cephalic vasomotor feedback,
one of which was a fifteen-year-old girl who had migraine
headaches.

Headache frequency and duration was not altered

by EMG feedback but both frequency and duration were
significantly reduced during cephalic vasomotor feedback.
Their subject was able to reduce EMG during EMG feedback
and reduce blood volume pulse during cephalic vasomotor
feedback.

In summary, no large-scale controlled outcome study of
behavioral interventions with children and adolescents who
have migraine headaches has been reported.

Skin temperature

feedback with children has been examined more than other
interventions, and even for this technique further research
is necessary to establish its efficacy for children who
have migraine headaches.

Shortcomings of studies to date

include small number of subjects,

lack of random assignment

of children to groups, no control group, no daily monitoring
of headache activity and lack of specified treatment plan.

PROBLEM

Childhood migraine is a prevalent disorder seen in
pediatric practice.

Migraine headaches can interfere with

a child's home and school life to the point that treatment
of this problem is often sought.

Traditional medical

treatments are available but serious side-effects may r e 
sult,

especially with long-term usage.

Behavioral approaches

to the treatment of migraine in adults have been successful,
a review of the literature indicating that relaxation train
ing, skin temperature biofeedback with autogenic training,
cephalic vasomotor feedback with EMG feedback and self
management procedures are more effective than no treatment
for adult m i g r a n e u r s .
Reports of behavioral approaches on the treatment of
childhood migraine have been rare.
EMG biofeedback,

Cephalic vasomotor and

contingency management and skin temperature

feedback with autogenic training have been reported to be
useful interventions.

Studies to date have consisted mostly

of single-case reports and one uncontrolled group study.
Of the interventions evaluated,

skin temperature feedback

with autogenic training has been investigated most frequently,
though only one published and three unpublished studies have
been completed.

Reports are interesting and promising but
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no firm statements can be made concerning the efficacy of
skin temperature feedback with children migraneurs from the
uncontrolled investigations.

Studies to date lacked random

assignment to conditions, had no control groups, used small
numbers of subjects and did not use objective outcome data.
Positive aspects of the studies have been well-defined
characteristics of subjects,

assessment of situational

patterning and clear descriptions of procedures.

The

clinical significance of such a problem as migraine hea d 
aches in children and the lack of relevant outcome data for
behavioral treatments with this population indicate research
in this area is needed.
The present study was designed to evaluate the effec
tiveness of a behavioral treatment with children migraneurs.
Skin temperature biofeedback with autogenic training and
home practice was the intervention studied.

Skin temperature

feedback with autogenic training was chosen because it is
a comprehensive package, has been successful with adult
migraneurs and preliminary reports indicate that it may be
effective with children.

Markman and Gottman (1978) suggest

when a new intervention is to be tested the first step is
to examine the effectiveness of the program as a whole and
if it is shown to be useful,

future studies can be employed

to dismantle the program.
The design of the present study attempted to overcome
some of the problems which existed with studies to date.
First,

the study was a controlled group outcome study.

A

waiting-list control group was compared to the treatment
group.

The control group was asked to monitor headache

activity throughout the study and received two attentionplacebo sessions in which baseline measures of skin
temperature were collected.

Second,

subjects were randomly

assigned to the treatment or waiting-list control group.
Third, objective outcome data of headache activity were
employed,

similar to measures used in the Labbe' and

Williamson (Ref. note 3) study.

All children recorded

headache activity during baseline,
phases of the study.

treatment and follow-up

Fourth, besides headache activity,

self-control of skin temperature was measured before and
after treatment of the experimental group and the control
group.

Skin temperature assessment was done to examine

the ability to increase skin temperature after treatment
for the experimental group as compared to baseline and to the
waiting-list control.

Fifth, maintenance of treatment ef

fects was assessed one month after treatment for the experi
mental group and was also compared to the waiting-list
control at follow-up.

Sixth,

a careful pre-experimental

headache assessment was made and only those children whose
headaches had no clear situational patterning were included
in the study.
Two basic hypotheses were tested.
Hypothesis 1 .

Those children receiving skin tempera

ture biofeedback with autogenic training will improve
significantly at the end of treatment and follow-up,

as

compared to a waiting-list control group, on dependent
measures of headache activity.
Hypothesis 2 .

Children receiving skin temperature

feedback will learn to increase skin temperature about
.5° Celsius after treatment as compared to the waitinglist control who will not show an increase in skin tempera
ture when asked to do so.

METHOD

Subj ects
- Children were referred by pediatricians in the community
and solicited through an article in the newspaper.
referral,

Upon

the child and at least one parent were interviewed.

The interview was structured using the Biographical Informa
tion Sheet and included behavioral assessment for situational
patterning of the child's headache and the completion of the
Headache Questionnaire by both the child and parent.

The

Biographical Information Sheet and the Headache Question
naire were adapted from a previous questionnaire used by
Cinciripini et al.

(1981) and Blanchard et al.

studies of h e a d a c h e s .

(1978) in

Parents and children were asked to

sign a medical consent form.

See appendices A through D for

interview materials, medical and subject consent forms.
Thirty children were interviewed who meet the criteria
of migraine headache.

Twenty-eight of the children attended

the first pre-treatment desensitization session.

The child

ren who attended the first session were matched on age, sex
and baseline headache index and then randomly assigned to
either a treatment group or waiting-list control group.
Ages of the children ranged from 7 to 16, mean age=10.82.
Fourteen of the subjects were female and 14 were male.

30

Criteria for inclusion.

To be included in the study

the child had to have received a secondary diagnosis of v a s 
cular

or

migraine headache by a physician and report at

least 2 migraine

headaches per

month and also meet

of the following

six criteria:

1) headaches are

predominantly one-sided

2) headaches are

usually accompanied by nausea

three

or vomiting

3) relief after rest
4) positive family history for migraine headaches
5) pulsating or throbbing pain
6) visual,

sensory or motor prodromes.

Dependent Measures
The method for computing headache data developed by
Blanchard et al.

(1978) was employed in this study.

Sub

jects were given headache booklets in which they recorded
four times per day (breakfast,

lunch,

dinner and bedtime)

the intensity of the headache on a scale from 0 to 5.

The

ratings were described as follow:
0 No headache.
1 Very mild headache,

aware of it only when attending

to i t .
2 Mild headache,

could be ignored at times.

3 Moderate headache, pain is noticeably present.
4 Severe headache,

difficult to concentrate,

can do

undemanding t a s k s .
5 Extremely intense headache,

incapacitated.

Subjects were asked to record during the baseline phase
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the type and quantity of all medications they took for
hea d a c h e s , as well as where and what happened after they
reported the headaches to an adult.

For the treatment and

follow-up phases the children were not asked to record
where and what happened after they reported the headache to
an adult.

Parents were asked to aid the children in record

ing their headaches and not to begin use of new medications
for the headache.
Clinical v a r i a b l e s .

Data from the headache records

were used to generate weekly scores on several clinically
meaningful variables.

The five scores are as follows:

1) Headache per week--number of discrete daily hea d 
aches per week.

To be scored as a headache,

there had to

be a rating of zero before and after each headache for that
day.
2) Headache index--average headache rating for the week.
The headache index was calculated by summing all of the rat
ings for a week and then by dividing them by 28 or the number
of rating intervals for that week.
3) Highest headache intensity per week--the single
highest headache rating for the week.
4) Average peak headache intensity per week--average
of the highest headache ratings for each discrete headache
experienced each week.
5) Headache duration— average length of headaches of intensity
2 or greater.
6) Medication index--the medication index was computed
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by multiplying the number of pills taken by the potency
rating.

A scale adapted from Sargent et al.

(1973) for

rating potency of medication was employed (see Appendix E ) .
Data on the place,

time and the consequences of re

porting headaches were reviewed and analyzed for situational
patterning of headaches.

For all the children, no obvious

patterns for operant pain were discerned.
Appartus
All experimental sessions were conducted in a two-room
laboratory with a one-way mirror.

The subject was separated

from the experimenter and physiological recording equipment
in a semi-sound proof room.

The fingertip temperature of

each subject was measured using a temperature thermistor
and a Analogue-to-Digital Converter, Med Associates

(ANL-90).

The temperature was monitored from the volar surface of the
most distal phalange of the left index finger.
responses were reported in degrees Celsius.

Temperature

Automatic count

ing of Celsius degrees of the fingertip temperature was a c 
complished using a Med Associates printout counter.

Finger

tip temperature biofeedback was provided using a Med A sso
ciates feedback volt meter with a full scale meter deflection
of 7cm.

Feedback sensitivity was manipulated by calibrating

the temperature channel so that a 3.0° change produced a
full scale deflection of the feedback needle.

Also, auditory

feedback was provided using a Med Associates voltage con
trolled audio oscillator and amplifier (ANL-910).
children were given temperature bands

The

(Biotic-Band II) for

home practice.

The temperature band was used to indicate

finger temperature.
crystal,

It was made of thermochromic liquid

and wrapped around the finger.

It has a range

of 20° Fahrenheit divided into 2 degree intervals which
are indicated on the band by printed n u m b e r s .
Procedure
A controlled group outcome design was used with each
child being assigned to either the treatment group or the
waiting-list control group.

The length of baseline for

both groups was four weeks.

During the baseline phase,

subjects were requested to fill out daily headache records.
Both groups were asked to attend two pre-treatment sessions
and one post-treatment sessions.

The first pre-treatment

session was designed to desensitize the children to the
laboratory.

It involved attaching a thermistor to the

subject for recording fingertip skin temperature.
ature response was recorded during all sessions.

Temper
The sub

ject was asked to sit for 15 minutes without any instruc
tions,

then to relax for 15 minutes as best he or she could

For the second pre-treatment and post-treatment sessions,
the subject was asked to sit quietly for 15 minutes,

then

asked to try to raise finger skin temperature as best he or
she could.
The waiting-list control group was then instructed to
keep headache records during the next two months
ment phase for the experimental group)
after this phase.

(the treat

and for one month

Two months after the treatment of the

experimental group was completed,

the waiting-list control

group was given the opportunity for treatment.
For the experimental group,

each child participated in

10 treatment sessions lasting about 40 minutes each.

These

sessions were spaced across a treatment period of 7 weeks,
two sessions per week for the first three weeks,
week for the last four weeks.
sessions consisted of 2 phases.

one per

The first 9 treatment
The first phase lasted 15

minutes and the child was given no instructions except to
sit quietly.

The first 10 minutes of phase 1 was provided

to allow the child to habituate to the situation and to
adjust the physiological recording equipment.
minutes of phase 1 was used as baseline.

The final 5

The second phase

consisted of 3 minutes of self-control of skin temperature
in the absence of feedback,

15 minutes of temperature feed

back and 3 additional minutes of self-control of skin
temperature in the absence of feedback.

The tenth treat

ment session consisted of 10 minutes of adaptation,

5

minutes of baseline and 15 minutes of self-control of
skin temperature.
For the first treatment session,

the operation of the

skin temperature feedback system was explained to the child
and he/she was given the expectancy that learning to warm
the hands is easy to do and will lead to improvement of
headaches.

Subjects were given autogenic training instruc

tions indicating how to imagine their hands becoming warm
as well as how to relax.

The instructions were as follows:

"Body reactions can be produced by your brain through
thoughts.

For example, when you think you are scared of

something you may notice that your heart begins to beat
faster.

Another example would be if you are worried about

doing well on a test or competition you may feel funny in
your stomach.

We are going to train you to produce changes

in the temperature in the skin of your hand.

If you learn

how to do this your headaches will become better.
this,

sit in a comfortable position.

particular images--warm mittens,

To do

You can think of

fireplaces,

individual variations and preferences h e r e ) .

etc.

(explore

Think about

these things and let the muscles in your body relax.
"You will notice that when you begin warming your skin
temperature the needle on the meter will move to the right
and a sound from this speaker will become higher.

(The

experimenter will demonstrate feedback devices by placing
the thermistor first on a cool surface,
temperature,

for decreasing

then by blowing on the thermistor,

ing temperature.)

for increas

This lets you know you are increasing

your skin temperature and should continue to do s o .
"Don't try too hard.

If you don't do it right away,

relax and try to think of warm things and soon your hand
will be getting warm."
For two of the children autogenic instructions did not
produce the desired temperature increase.

They were then

instructed to focus on a certain sensation in their fingers
such as warmth and heaviness in the hand,

fingers and arm.
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The experimenter stayed in the room with each child and
continued verbal shaping until she/he was able to produce
increases in skin temperature.
Instructions about biofeedback and autogenic training
were repeated during the first 4 sessions.

The children

were then briefly reminded of the tasks during the remain
der of the sessions.
Each child was instructed to practice the autogenic
exercises and hand warming for about 10 minutes twice
daily at home and to keep a record of home practice in the
headache booklet.

At the fourth treatment session each

child was given temperature bands and was instructed to
use it during the remainder of the treatment phase and
one-month follow-up when practicing at home.

Instructions

were as follows:
"To help your headaches go away,

and not come back,

you must practice at least twice a day for about 10 minutes.
Do the same thing that you do when you are here.

You can

use the temperature band to let you know when your finger
is getting warmer.

Remember it is your responsibility to

practice and it is very important to do so."
In order to increase compliance with headache self
monitoring,

all children were given a gold star for each

headache booklet they turned in.

When a child collected

11 stars they were rewarded with a small present valued at
about $1.50.

When follow-up records were completed and

sent in, the child's name was placed in a lottery to win
$30.00.

RESULTS

Data Analysis
Headache v a r iables.

Dependent measures of headache

activity were computed as described in the procedure sec
tion.

The six variables or scores of headache activity

were:

headaches per week, headache index, highest headache

intensity per week,
week,

average peak headache intensity per

average length of headache of intensity of 2 or

greater and medication index.
of baseline,

The data from the 4 weeks

last 2 weeks of treatment and 4 weeks of

follow-up were used.

An average score for each phase was

computed for each headache v a r i a b l e .
Data analyses examined differences in headache activ
ity within groups over baseline,

treatment and follow-up,

as well as differences between the treatment and waitinglist control group at each phase.

A 2x3 analysis of vari

ance (ANOVA) with one repeated measure was employed to
test differences between the treatment and control groups
on the six variables at baseline,

treatment and follow-up.

Post-hoc analyses of simple effects included one-way
ANOVAs and the Newman-Keuls statistic.

ANOVAs-were employed

to determine whether groups were significantly different
at baseline,

treatment and follow-up phases for all headache
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variables.

Newman-Keuls tests were used for individual group

comparisons of headache data across phases,
treatment and follow-up.

i.e., baseline,

An alpha level of p < . 0 5 was

used for all statistical analyses.
Skin temperature d a t a .

The ability to increase skin

temperature was examined for the control and treatment
groups by determining the average skin temperature during
the two phases of the pre-treatment and post-treatment m e a s 
urement sessions:

5 minutes of baseline and 15 minutes of

temperature self-control.
phase was the average of
during each phase.

The skin temperature for each
10

second interval recordings

Difference scores were determined for

each subject by subtracting the baseline from the selfcontrol average.

Difference scores were determined for the

pre-treatment and post-treatment sessions.

A two-way

analysis of variance with one repeated measure was used to
analyze the difference in skin temperature change between
the two groups,’ as a function of the treatment.

Due to a

temporary malfunctioning of the heating system, which
created an unusually cold experimental environment,

three

children from each group were excluded in the a n a lyses.
Reliability Checks
Computation of headache data was independently checked
by a second

student, using a

20%

sample that was randomly

chosen from the headache records.

One-hundred percent

agreement was obtained for frequency of headaches, highest
intensity per week and medication index,

98% agreement was
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obtained for headache index and average peak intensity per
week and 93% agreement was obtained for duration of h e a daches.
Computation of the skin temperature data was independ
ently checked by a second person and

100%

agreement was

obtained.
Headache Data
Results of the analyses of each headache variable will
be discussed separately and then summarized in a section
describing the clinical significance of the findings.

Skin

temperature data will also be presented in a separate
section.
Headache i n d e x .

The results of the analyses indicate

that the groups did not differ on headache index during the
baseline phase.

At the end of treatment,

the treated group

differed significantly from the waiting-list control,

in

dicating substantial improvement as a function of treatment.
The improved headache index scores of the treated group were
maintained at the one-month follow-up.

Figure 1 displays

changes across treatment phases of the mean headache index
for the waiting-list control group and treatment groups.
Refer to Table 1 for a summary of the statistical analyses.
As shown in Figure 1, headache index for the treated group
was substantially reduced as a function of the skin tempera
ture biofeedback, where as the headache index of the control
group did not improve over the treatment or follow-up
periods.

Post-hoc comparisons of the treated group's h e a d 

ache index at baseline,

treatment and follow-up demonstrated
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Figure 1.

• Skin temperature feedback

Mean headache index scores per week for both

skin temperature feedback and waiting-list control groups
at baseline,

treatment and one-month follow-up phases.

scores were significantly lower than baseline value at the
end of treatment and at one-month follow-up.

No difference

between the end of treatment and follow-up headache index
was found for the treated g r o u p , indicating the treatment
effect was maintained.

Headache index for the control group

remained stable across all three treatment phases.
Table 1
Summary Table of Analyses of Variance
for Headache Index
Source
Between Subjects
Condition
Error b
Within Subjects
Trials
TrialxCondition
Error w
Total

SS

df

MS

9.80
2.54
7.26
2.30
.34
.45
1.34
11.93

27

_

Headache frequency.

1

26
56
2
2

52
83

2.54
.28
-

.17
.23
.03
—

F

P

_

9.07

<.005

-

-

-

-

5.67
7.67

<.001
<.001

-

—

—

The results of the analyses in-

dicate that the groups did not differ on. headache frequency
during the baseline phase.

The treated group improved

significantly at the end of treatment as compared to the
waiting-list control group.

The improved headache frequency

of the treated group was maintained at the one-month followup.

Figure 2 displays changes across treatment phases of

the mean headache frequency scores of the waiting-list
control and treatment g r o u p s .

Refer to Table 2 for a sum

mary of the statistical analyses.
As shown in Figure 2, headache frequency for the
treated group was substantially reduced as a function of
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Figure 2.

• Skin temperature feedback

Mean headache frequency per week for both

skin temperature feedback and waiting-list control
groups at baseline,
phases.

treatment and one-month follow-up

the skin temperature biofeedback, where as the headache
frequency of the control group did not improve over the
treatment or follow-up periods.

Post-hoc comparisons of

the treated group at each phase of the study demonstrated
scores at the end of treatment and at one-month follow-up
were significantly lower than baseline values.

No dif

ference between the end of treatment and follow-up was
found for the treated group indicating the treatment effect
was maintained.

In contrast, headache frequency for the

control group did not change during baseline,

treatment or

follow-up.
Table 2
Summary Table of Analyses of Variance
for Headache Frequency
Source

SS

Between Subjects
Condition
Error b
Within Subjects
Trials
TrialxCondition
Error w
Total

329. 85
26. 8 6
302. 99
113. 34
13. 50
1 2 .89
8 6 .95
443. 19

Headache D u r a t i o n .

df

MS

F

P

.48
-

NS
-

27
1

26
56
2
2

52
83

26.86
50.50
-

6.75
6.45
1.55

-

-

4.04
3.86

<.05
<.05

-

-

The results of the analyses indi

cate that the groups did not differ on headache duration
during the baseline phase.

The treated group improved and

differed significantly in comparison to the waiting-list
control group.

Improved headache duration of the treated

group was maintained at the one-month follow-up.

Changes

across treatment phases of the mean headache duration

scores of the waiting-list control and treatment groups
are displayed in Figure 3.

Refer to Table 3 below for a

summary of the statistical analyses.
Table 3
Summary Table of Analyses of Variance
for Headache Duration
Source

SS

Between Subjects
Conditions
Error b
Within Subjects
Trials
TrialxConditioh
Error w
Total

365,,12
328,.12
536,.89
370.,38
57..50
93..57
219.,31
1235..50

df

MS

1
2
2

52
83

P

_

27
26
56

F

41. 39
1 . 69

24.49

<.001

-

-

28. 75
46. 79
4. 2 2

6.85
11.09

-

<.005
<.001

-

-

As shown in Figure 3 headache duration for the treated
group was substantially shortened as a function of the skin
temperature biofeedback;

in contrast the headache duration

of the control group did not improve over the treatment or
follow-up periods.
group at baseline,

Post-hoc comparisons of the treated
treatment and follow-up indicated a

significant reduction of headache duration at the end of
treatment and at one-month follow-up.

No difference between

the end of treatment and follow-up headache duration was
found for the treated group,
was maintained.

indicating the treatment effect

Headache duration for the control group did

not change across the treatment p h a s e s .
Highest Intensity Rating for the w e e k .

The results of

the analyses indicated the groups were not different on their
highest headache intensity rating during the baseline phase.

DURATION
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Figure 3.

§

Skin temperature feedback

Mean headache duration per week for both skin

temperature feedback and waiting-list control groups at
baseline treatment and one-month follow-up phases.

The treated group improved significantly during treatment
as compared to the waiting-list control.

The improved

intensity ratings of the treated group were maintained at
the one-month follow-up.

Figure 4 displays changes across

treatment phases of the mean highest intensity ratings of
the waiting-list control and treatment groups.

Table 4

summarizes the statistical analyses.
Table 4
Summary Table of Analyses of Variance
for Highest Intensity Rating
Source
Between Subjects
Condition
Error b
Within Subjects
Trials
TrialxCondition
Error w
Total

SS

df

115.31
48.96
66.35
67.96
21.76
21.44
24.76
183.27

27

MS

F

P

_

48.96
2.55

1

26
56
2
2

<.001

-

-

-

-

-

10.88

22.67
22.23

10.72
.48

52
83

19.20

<.001
<.001

-

-

—

—

As shown in Figure 4, highest intensity rating for the
control group did not improve.

For the treated group,

highest intensity rating was substantially reduced as a
function of the skin temperature biofeedback.

Post-hoc

comparisons of the treated group's highest intensity rating
at baseline,

treatment and follow-up demonstrated scores

were significantly lower than baseline values at the end of
treatment and at one-month follow-up.

No difference between

the end of treatment and follow-up highest intensity ratings
was found for the treated group.

In contrast, highest

intensity ratings for the waiting-list control group r e 
mained stable across the treatment phases.
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Figure 4.

Mean highest intensity rating per week for

both skin temperature feedback and waiting-list control
groups at baseline,
phases.

treatment and one-month follow-up

Average Peak Headache Intensity R a t i n g .

Analyses of

the average peak intensity rating found no group differ
ences at baseline.

The treated group differed reliably

from the waiting-list control group at the end of treatment.
The improved average peak intensity ratings of the treated
group were maintained at the one-month follow-up.

Figure

5 displays changes across treatment phases of the mean
average peak headache intensity ratings of the waitinglist control and treatment groups.

Statistical analyses

are summarized in Table 5.
Table 5
Summary Table of Analyses of Variance
Average Peak Intensity Rating
Source
Between Subjects
Condition
Error b
Within Subjects
Trials
TrialxCondition
Error w
Total

SS

df

85. 37
41. 39
43. 98
52. 91
1 1 .84
13. 57
27. 50
138. 28

27
1

26
56
2
2

52
83

MS

F

41.39
1.69

24.49

-

-

5.92
6.79
.53
—

P
<.001

-

-

11.17
12.81

<.005
<.001
-

-

—

As shown in Figure 5, average peak intensity for the
treated group was reduced as a function of treatment w h e r e 
as the average peak intensity rating of the control group
did not improve over the treatment or follow-up periods.
Post-hoc comparisons of the treated group's average peak
intensity ratings at each phase of the study indicated
scores were significantly lower than baseline values at
the end of treatment and at one-month follow-up.

No
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Figure 5.

Mean average peak intensity per week for

both skin temperature feedback and waiting-list control
groups at baseline,
phases.

treatment and one-month follow-up

difference between the end of treatment and follow-up
average peak intensity ratings was found for the treated
group,

demonstrating the treatment effect was maintained.

Average peak intensity ratings for the control group did
not differ across treatment phases.
Medication i n d e x .

Analyses of the medication index

indicate the groups did not differ significantly during
the baseline phase or at the end of treatment.

The groups

did differ significantly at the one-month follow-up phase.
Refer to Table

6

for a summary of the statistical analyses.
Table

6

Summary Table of Analyses of Variance
for Medication Index
Source

Figure

6

4878..71
8 8 .05
4790,.66
2025,.49
298..55
1 2 1 . 54
1605..40
6904..20

df

MS

1

2
2

52
83

P

__

27
26
56

F

8 8 .05
184. 26

00

Between Subjects
Condition
Error b
Within Subj ects
Trials
TrialxCondition
Error w
Total

SS

NS

-

-

-

149. 27
60. 77
30. 87

4.84
1.97

-

<.025
<.200

-

-

—

displays changes across treatment phases of the

mean medication index of the waiting-list control and
treatment g r o u p s .

From a visual inspection of the medica

tion index means for the two g r o u p s , it is clear that even
though the treated group's medication index was higher than
the waiting-list control at baseline it was much lower than
the control group's medication index at the end of treatment.
Post-hoc analyses of the data for each group across trials
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Figure

6

.

Mean medication index per week for both skin

temperature feedback and waiting-list control groups at
baseline,

treatment and one-month follow-up phases.
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were made because of the noticeable difference in the treated
group's medication use and because all other headache var i 
ables for the treated group showed a similar pattern of
improvement at treatment and follow-up.

Post-hoc comparisons

of the treated group's medication index at baseline,

treat

ment and follow-up demonstrated medication index was sig
nificantly lower than baseline values at the end of treatment
and at one-month follow-up.

No difference between the end

of treatment and follow-up medication index was found for
the treated group.

In contrast, medication index for the

control group failed to change significantly throughout the study.
Thus,

although the groups were not significantly different

at the end of treatment,

the treated children still improved

substantially in their medication usage as compared to their
baseline behavior.

This improved medication index was

significantly different from the waiting-list group at the
one-month follow-up.
Clinical Significance of the Results
The clinical significance of the results for the indi
vidual subjects can be presented in terms of the percentage
of subjects that were symptom free,

improved or not improved

at the end of treatment and follow-up.

"Symptom free" was

defined as a mean score of zero on any given headache
variable.

"Improved" was defined as half the baseline score

for the headache variables,

frequency, headache index,

duration and medication index.

For the headache variables

highest intensity rating and average peak intensity rating,

"improved" was defined as an average rating of 3 or less.
"Not improved" was defined as greater than half of the
baseline score for frequency, headache index,

duration and

medication index and as a rating of 4 or higher- for high
est intensity rating and average peak intensity rating.
Table 7 summarizes the percentage of subjects who were
symptom free,

improved or not improved at the end of treat

ment and follow-up phases for the treated and waiting-list
control g r o u p s .
For the treated group greater than 90% of the subjects
were either improved or symptom free on headache index,
highest intensity rating and average peak intensity rating
at the end of treatment and at follow-up.

In contrast,

none of the children in the control group were symptom free
and 14% or less were improved at the end of treatment and
follow-up on these same dependent variables.
Frequency of headaches for 72% of the treated group
was improved or symptom free.

The percent improved or

symptom free increased to 93% at the one-month follow-up.
In comparison,

93% of the waiting-list control group were

rated as unimproved at the end of treatment and at the
one-month follow-up.
The duration of headache score was defined as the
average length of headaches of intensity of

2

or greater.

Thus, of the 50% of the children included in the symptom
free percentage at the end of treatment,

some children were

still experiencing very mild headaches.

At the one-month

Table 7.
Percent Symptom Free, Improved or Not Improved
Headache
Variable

Symptom Free

Treatment
Improved*

Not
Improved
Txt. WLC

T x t . WLC

Txt. WLC

Headache
Index

36%

0%

57%

7%

7%

Frequency

36%

0%

36%

7%

Highest
Intensity

36%

0%

64%

Average
Peak

36%

0%

Duration

50%

Medication
Index

79%

Symptom Free

Follow-Up
Improved*

Not
Improved
Txt. WLC

Txt. WLC

Txt. WLC

93%

21%

0%

72%

14%

7%

86%

28%

93%

21%

0%

72%

7%

7%

93%

7%

0%

93%

21%

0%

79%

14%

0%

86%

64%

7%

0%

93%

21%

0%

79%

29%

0%

71%

0%

21%

7%

29%

93%

21%

0%

50%

14%

29%

86%

36%

21%

14%

0%

50%

79%

21%

21%

7%

0%

72%

* Improved scores for frequency, headache index, duration and medication
index were rated as improved if they were 1/2 the baseline value.
For
highest intensity and average peak intensity at score of 3 or less was
rated as improved.

follow-up,

only 21% were symptom free.

children were included,
duration.

However,

if improved

71% experienced relief in headache

For the waiting-list control group,

93% of the

children's headache duration scores were rated as unimproved
at the end of treatment and

86%

were unimproved at follow-up.

It is interesting to note a large percentage of both
as 797o of the treated

groups improved on medication index,

group and 36% of the waiting-list control group had dis
continued use of medication at the end of treatment.
ever,

22%

How

of the waiting-list control children who had

improved at the end of treatment returned to baseline
medication use at follow-up.

None of the treated children

returned to baseline medication use at the one-month follow-up
i

Skin Temperature Data
Statistical analyses of the skin temperature data
showed that groups differed, though not significantly, at some
phase of treatment at the .1 level.

Refer to Table

8

for a summary

table of the analyses.
Table

8

Summary Table of Analyses of Variance
for Skin Temperature
Source
Between Subjects
Condition
Error b
Within Subjects
Trials
TrialxCondition
Error w
Total

SS
21.92
.66

21.26
12.87
.57

df

MS

20
1

.661

19

1.68

21
1
1

10.62
34.79

19
41

_

1

F

P

_

.59

NS

120

-

-

-

-

-

.574
1.680
.560
-

1.03
3.01

-

<•1

-

-

-

-

Figure 7 displays the means at pre- and post-treatment
sessions for the two groups.

To determine whether the

groups were comparable at baseline a one-way ANOVA was
performed.

The groups did not differ significantly;

F ( 1 ,19)=2 .90, p > .05.

Inspection of the mean skin tempera

ture difference scores at baseline showed that the waitinglist control group increased their skin temperature by

.48

degrees Celsius at the pre-treatment session whereas the
treated group's mean skin temperature difference score was
decreased by

.18.

treatment sessions

Comparison of the groups at the p ost
was also nonsignificant;

F(l,20)=.14,

p>.05.
Further analyses comparing each group's mean skin
temperature difference scores at pre- and post-treatment
sessions were made.

The group receiving feedback was able

to raise their skin temperature without feedback signifi
cantly ( p < . 0 1 ) at the end of treatment as compared to
pre-treatment performance.

The waiting-list control group's

pre-treatment mean skin temperature difference score was
not significantly increased as compared to post-treatment
performance.

Also,

their mean skin temperature difference

score was slightly lower at the post-treatment session.

PRE

POST
SESSIONS

0-------- 0

Waiting-list control

0-------- 0

Skin temperature feedback

Figure 7.

Mean skin temperature difference scores for

the skin temperature feedback group and the waiting-list
control group at pre- and post-treatment sessions.

DISCUSSION

Results of the study support the effectiveness of skin
temperature biofeedback with autogenic training and home
practice for the treatment of migraine headaches in child
ren.

All six headache variables improved for the treatment

group and remained the same for the waiting-list control
group during the treatment and follow-up phases.

Medica

tion index was not as clearly improved at the end of treat
ment as the other headache variables.

The waiting-list

control group did not differ on the medication index at the
end of treatment and follow-up as compared to their baseline
medication index.

The groups did not differ at the end of

treatment, but the treated group's medication index at the
end of treatment was significantly lower than their baseline
scores.

The treated group was significantly improved at

the one-month follow-up for medication index as compared
to the waiting-list control group.
The headache data suggest that skin temperature b i o 
feedback improves headache in all p a rameters.
index,

Headache

the most general headache variable, was significantly

decreased at the end of treatment and at follow-up for the
treated group.

Children receiving skin temperature feedback

also experienced a statistically significant reduction in
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the pain level of their headaches as both highest headache
intensity rating and average peak headache intensity rating
were significantly reduced at the end of treatment and at
the one-month follow-up.

The time length of headaches was

also significantly reduced for the treated group as compared
to the waiting-list control at the end of treatment and
effects were maintained at the one-month follow-up.
of the reduction in intensity,

Results

duration or severity of the

headaches are similar to results evaluating the effective
ness of skin temperature biofeedback with autogenic training
w ith adult migraineurs

(Blanchard et al.,

1978).

The number of headaches per week was significantly r e 
duced at the end of treatment and at the one-month follow-up,
although the difference between groups for frequency of
headaches was not as great as the reduction of the severity
of headaches.

Blanchard et a l . did not find a significant

decrease in frequency of adult headaches with skin tempera
ture biofeedback.

However,

the few child studies that have

reported using skin temperature biofeedback with autogenic
training have all reported both a decrease in frequency and
intensity of headaches
et al.,

(Diamond & Franklin,

in press; L a b b e 1 5c Williamson,

5c Grossman,

ref. note

2).

1975; Andrasik

ref. note 1; Pepper

Thus the finding of a significant

reduction in number of headaches per week as well as a d e 
creased intensity of headache is consistent with previous
child studies in the area.
Both groups reduced medication usage at the end of

treatment and their medication scores were not significantly
different as compared to each other.

Although the groups

were not different at the end of treatment,

the treated

group's medication index score was significantly different
at the end of treatment as compared to their baseline usage.
The waiting-list control group's medication index was r e 
duced but not to a statistically significant degree.

The

waiting-list control group's medication usage returned to
baseline level at follow-up.

In comparison,

the treated

group's reduced medication usage was maintained at follow-up.
Results of a decrease in medication usage is also similar
to results of adult studies and preliminary studies with
children in the treatment of migraine hea d a c h e s .
Results of the study were not only statistically
significant but also clinically relevant.

Examination of

percent symptom free or improved suggests that most of the
children in the treated group experienced improvement of
their migraine h e a d a c h e s .

At the end of treatment only 7%

of the waiting-list control group had spontaneously im
proved on headache index, highest headache intensity rating,
average peak headache intensity rating,
duration.

frequency and

At follow-up 14% of the waiting-list control

spontaneously improved on headache index, highest headache
intensity rating and duration of headache,

7% continued to

be improved for frequency of headaches and 29% experienced
improvement of average peak headache intensity rating.
The modest degree of spontaneous improvement for the
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waiting-list control subjects are consistent with the
general treatment outcome literature of studies using n o 
treatment control groups

(Garfield & Bergin,

1978) .

The treated group showed the greatest improvement on
the variables concerning intensity of headaches, with

100%

of the children either improved or symptom free at the end
of treatment and a one-month follow-up.

At the one-month

follow-up both headache index and frequency were greatly
improved (93%) whereas only 71% of the treated children
experienced a reduction in duration of headache.
One clinical anecdote may be useful for understanding
how some children were able to control h e a d a c h e s .
to treatment,

Prior

one of the treated children experienced

parathesias of the left side of his body during the pr e 
headache phase and extreme pain (usually rated as 5) during
the headache phase.

The child required numerous visits to

the emergency room where he usually received injections of
demerol.

Following treatment,

the child successfully

employed the hand warming technique to abort the pre-headache
(prodromal) phase,
occur.

consequently the headache phase did not

He attempted to increase his skin temperature in

his hand for about

20

minutes whenever he felt the onset of

parathesias, which usually began in his left toes.
other children reported, with great excitement,

Several

similar

successes in aborting or greatly decreasing head pain by
using the hand warming procedure during the prodromal phase.
Children reported enjoying the treatment program.

It
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is interesting to note that throughout the treatment ses
sions only 5 out of 140 scheduled treatment sessions had
to be rescheduled.

High attendance rate is one indication

that the children found the sessions to be rewarding and
worth w h i l e .
One potential problem with the results of this study
is the use of self-report data.

Some may criticize the

reliability of children reporting their own pain behavior.
During the study, parents and children were often reminded
of the importance of accurate and current recordings of
headaches.

Parents were asked to check daily on the child's

headache booklet.

Headache booklets were turned in on a

weekly basis and checked by the experimenter;
occurred,

if headaches

the experimenter discussed the headache with the

child and explored how the child attempted to resolve the
pain,

e.g., hand warming, medication,

sleep.

Children r e 

ceived a gold star for each booklet turned in and rarely
did a child forget to do so.

Prompt response in turning

in booklets and experimenter's observation of parent's and
child's discussion of headache activity suggest the selfreport data was probably fairly reliable.
In summary,

analyses of the headache data, observations

by the experimenter and reports by the parents of the
children's interest and home practice indicate the children
were able to successfully utilize the treatment procedure
at the clinic as well as in the home.

Results of the present

study are similar to results of studies using skin temperature

biofeedback in the treatment of migraine with adults.

The

present study also extends the findings of the Diamond and
Franklin (1975) single group study and several case studies
(Andrasik et al.,

in press; Labbe' & Williamson, ref. note

3; Pepper 5c Grossman,

ref. note 2) in that a controlled

group outcome design was used to evaluate headache activity
and medication intake.
group outcome design,

Because the study used a controlled
it provides support for the external

validity of the technique as an effective treatment of
childhood migraine h e a d a c h e s .
niques available today,

Of the psychological tech

skin temperature biofeedback with

autogenic training has been the most widely researched
treatment approach for childhood migrai n e u r s .

Given the

results of the present study, one can reasonably conclude
that it is a very effective treatment for childhood migraine.
Replication of the present study is important for further
support of the effectiveness of the skin temperature b i o 
feedback with autogenic training in the treatment of child
hood migraine.

Future studies should focus on component

analysis of the treatment program to elucidate which com
ponents of the program are necessary for reducing headache
a c t ivity.
The skin temperature data indicate that the children
in the treated group were able to significantly increase
their finger temperature at the end of treatment as com
pared to their pre-treatment performance.

Prior to treat

ment the treated group decreased their average baseline
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skin temperature by an average of .18 degrees Celsius during
the self-control phase.

At the end of treatment the child

ren were able to increase their skin temperature by an
average of

.48 degrees Celsius with no feedback,

increasing their skin temperature by

actually

.66° Celsius as com

pared to their performance at pre-treatment.

Their ability

to increase their skin temperature with no feedback at the
end of treatment supports the initial hypothesis that
treated children would be able to increase their skin
temperature by about

.50° Celsius at the end of skin tempera

ture biofeedback training.
The finding that the waiting-list control group were
able to increase their skin temperature by
prior to treatment was unexpected.

.47° Celsius

They increased skin

temperature at the end of treatment but not significantly
so as compared to baseline performance.

The results of the

skin temperature data raise the interesting and controver
sial question of how is the ability to increase skin
temperature related to headache outcome.

Researchers are

becoming more concerned with the question of the psychophysiological basis of therapeutic benefits of biofeedback
and other behavioral interventions and several interpreta
tions have been put forth (Elmore & Tursky,
Cincirpini et a l ., 1981; Williamson,

1981).

1981;
Given the

number of subjects receiving feedback training and the
limited use of psychophysiological assessment the present
study can not adequately address the issue of the
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psychophysiological basis of the therapeutic effects of
skin temperature biofeedback with autogenic training,
although some speculation can be put forth.
One hypothesis is that treatment was effective because
by using the self-control phase at the home and the clinic,
whether or not they actually produced skin temperature
changes,

a relaxation response was induced.

This relaxa

tion response, by decreasing general sympathetic arousal
on a daily basis, influenced headache activity.
for a nonspecific effect,

such as relaxation,

basis of therapeutic benefit

is

Support
to be the

the Mullinix et a l . (1978)

study in which false feedback also resulted in decreased
headache activity as well as studies comparing and finding
similarities in the effectiveness of relaxation training
and skin temperature feedback (Williamson,

198).

Recent

biochemical studies report findings that strengthen the
position that biofeedback influences sympathetic adrenomedullary activation by reducing sympathetic tone (Mathew,
Weinman,

& Largen,

1982).

Reduction in plasma catecholamines

and platelet monoamine oxidase are thought to occur with
biofeedback assisted relaxation.

A second interpretation

is that skin temperature biofeedback with autogenic train
ing may be successful because of the effect it has on
cephalic vasomotor response, particularly during the p r e 
headache phase.

The children who used the technique when

they thought a headache would soon occur could often abort
or reduce headache pain.

This observation suggests the
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children may have learned to reduce cephalic vasoconstric
tion of the pre-headache phase which led to a reduction of
the "rebound" vasodilation of the headache phase.
temperature biofeedback,

Skin

then, may have a palliative effect

by decreasing general sympathetic arousal and/or a direct
effect by reducing the "rebound" vasodilation of the hea d 
ache phase.

It may be the case that the underlying b i o 

chemical changes for both of these explanations is the same.
In conclusion,

the skin temperature data, although not

differentiating between groups at the post-treatment session,
did show the treated group was able to significantly increase
their skin temperature at the end of treatment as compared
to pre-treatment performance.

Their ability to increase

their finger skin temperature on the average of
is consistent with adult research.

.48° Celsius

There are no normative

data on children's hand warming ability with or without
feedback with which to compare the results of these skin
temperature data.

A study investigating normative data on

children's hand warming ability is needed.

Further studies

investigating skin temperature feedback with children
should replicate the procedure used to evaluate the ability
to increase skin temperature in the absence of feedback,
before and after treatment.

To shed light on the psycho-

physiological phenomenon associated with treatment outcome,
further studies should include more responses in their
psychophysiological assessment,
assessment.

as well as biochemical
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Summary
The present study attempted to address two hypotheses.
One hypothesis stated children receiving skin temperature
feedback would be able to raise their skin temperature by
.5° Celsius and this would be significantly different from
the waiting-list control group.

Another hypothesis stated

children migraineurs receiving skin temperature biofeedback
with autogenic training and home practice would significantly
improve on selected measures of headache activity as compared
to a waiting-list control group.
The first hypothesis was supported in that children
receiving skin temperature feedback training were able to
significantly increase their finger skin temperature at the
end of treatment as compared to baseline performance.

There

were no significant differences in the waiting-list control
group's performance at pre- and post-treatment sessions.
Firm conclusions can not be made regarding the skin tempera
ture data as the waiting-list control group did increase
their temperature at pre- and post-treatment sessions and
their skin temperature difference scores were not signifi
cantly different from the treated group at the post-treatment
session.
The second hypothesis was strongly supported.

The

treatment was successful as the treated group did signifi
cantly improve on all six headache variables and the waitinglist control did not.

Thus skin temperature biofeedback

with autogenic training and home practice appears to be an

effective behavioral intervention for the treatment of
childhood migraine.

The present study's contribution to

clinical psychological research is that it is the first
controlled experimental demonstration of the effectiveness
of skin temperature biofeedback with autogenic training
for childhood migraine.
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Appendix A

Biographical Information
Name:

Date:

Age:

Sex:

B ir t h d a t e :

Race:

Grade:

School:

Address:

Phone N u m b e r :
No

1.

Headaches are a problem for me.

Yes

2.

I take medications for relief of head pain.
No _____

3.

I have had headache problems since the age of __

4.

I have approximately

5.

I have been to the doctor for care of my headaches.
Yes
No

6.

If yes, his diagnosis was _____________________________

7.

What,

8.

Have you had any of the following:

Yes

headaches per month.

if any, medications has he prescribed for you?

eye problem ______________
ear problem ______________
dental problem ___________
sinus problem ____________
head injury ______________
seizures _ ______ _____
other neurological problems ______________
If you have had any of the above, how have they been
related to your headache?
9.

Have your headaches changed in frequency,
intensity during

duration or

GIRLS-Menstruation
Increase
Decrease______
BOYS-Beginning of puberty
Increase _____ Decrease____

77

78

10.

I have been under stress which may be related to my
h e a d a c h e . Yes
No _____

11.

Do you smoke? _____ How much? _____

12.

Have you ever suffered from car sickness?
No _____

13.

Have you ever suffered from high blood pressure?
Yes _____ No______

14.

Do you suffer from high blood pressure?
No _____

15.

Do you have a parent who suffers from headaches?
Yes _____ No______

16.

Does any other family member suffer from headache?
Yes _____ No______

17.

Is there a seasonal pattern to your headache?
Yes _____ No______

Yes

Yes

If y e s , when ___________________________________________
18.

Do you have difficulty sleeping?

Yes ______ No_____

If yes, please describe your difficulty.____________

19.

Do you wet the bed at night after a headache?
Yes ______ No______

20.

Are you involved in extra curricular activities?
Yes ______ No______
What are they? _____________________________________

21.

What kinds of grades do you make? ____________________
Do your headaches interfere with school or homework?
Yes
No
Notes or Comments:

w
>
w
s

4
!
Dd
3

co

>1

H
H

►J
<3
P
CO

&

ALWAYS
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O
CO

Does your headache occur
in school
home
other

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

1
1
1
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

4
4
4
4
4
4
4

5
5
5
5
5
5
5

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

4
4
4
4
4

5
5
5
5
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Do headaches occur during the
morning
afternoon
sleep
all day
weekdays
weekends
certain days
Do headaches occur when the following
people are present
parents
siblings
friends
teachers
other
When at home
What is the child doing before a headache?

Notes or C o m ments:
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<
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4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5

What happens when a headache is reported?
medication is given ____________
rest
like to be alone
special requests _______________
special treats
stays home from school
does not do housework
does not do homework

1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

3
3
3
3

4
4
4
4

5
5
5
5

When at school
Are there certain classes the child
reports headaches in?

What happens when the child reports a
headache?
rest
medication
goes home
does not do school work
Notes or C o m ments:

1
1
1
1

2
2
2
2
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For the next two questions please
refer to the figures below.
1.

2.

Pi
W
>
w
a

When I get a headache, the most
severe pain occurs in area(s)
When I get a headache,
pain in area ( s ) :

><
►J
w
pi

a

co
§
H
H

CO

►*
t-J
J
<3
ZD
CO

5?

<d
!3

O
CO

I experience

only 1

1

2

3

4

5

only 2

1

2

3

4

5

only 3

1

2

3

4

5

only 4

1

2

3

4

5

only 5

1

2

3

4

5

only 6

1

2

3

4

5

only 1 & 2

1

2

3

4

5

only 1 & 4

1

2

3

4

5

only 1 & 6

1

2

3

4

5

only 1, 4 & 6

1

2

3

4

5

only 2 6c 3

1

2

3

4

5

only 2 6c 5

1

2

3

4

5

only 2 ,

1

2

3

4

5

1

2

3

4

5

3 6c 5

only 3 6c 4
only 1 ,

2,

3 6c 4

1

2

3

4

5

only 1 ,

2,

3,

1

2

3

4

5

<0>

4 , ' 5 6c 6

Appendix B

HEADACHE QUESTIONNAIRE
Name

Date

DIRECTIONS:
The following statements
describe symptoms which occur with dif
ferent types of h e a d a c h e s . Read each
statement carefully and then circle the
answer which is most correct for you.
The 5 possible answers are defined as
follow: Always (occurs without excep
tion) , Sometimes (occurs approximately
Pd
half the t i m e ) , Rarely (occurs only
w
>
once in a great while) Never (absolutely
w
does not occur and has not ever occurred). 3

>■<
y
W

Pd

co

y
H

H

y
o

CO

y
y
c
y
CO
y

>\
<
y

c

CO

1.

I awaken with a h e a d a c h e .

1

2

3

4

5

2.

My headache

lasts less than

1 hour.

1

2

3

4

5

3.

My headache

lasts from 1 to

4 hours.

1

2

3

4

5

4.

My headache

lasts from 4 to

8 hours.

1

2

3

4

5

5.

My headache

lasts from 8 to

10 h o u r s .

1

2

3

4

5

6.

My

lasts from 10 to

24 hours

1

2

3

4

5

7.

My headache lasts for more than 24
hours.

1

2

3

4

5

8.

I have a headache most of the time.

1

2

3

4

5

9.

Before or during a headache I have
blind spots in visual field.

1

2

3

4

5

10.

Before or during a headache I see
stars or flashing lights.

1

2

3

4

5

11.

Before or during a headache I have
double vision or blurry vision.

1

2

3

4

5

12.

Before or during a headache bright
lights bother m e .

1

2

3

4

5

headache

82

83
pi

SH

W
>

w

H

2

a

2

<5

<*)

W

S

C/3

HJ

fH
hJ

I—•

<J

h

cd

c

J3
hJ

w w
S
3
o

<

CO

13.

Before or during a
noise bothers me.

headache loud

1 2

3

4

5

14.

Before or during a
come dizzy.

headache I be-

1 2

3

4

5

15.

Before or during a headache parts of
my body, eye, hand, mouth, tongue,
are n u m b .

1 2

3

4

5

16.

I take a prescribed medication on a
daily basis in order to control
h ea d a c h e s .

1 2

3

4

5

17.

My headache begins
while sleeping.

1 2

3

4

5

18.

My headache starts after drinking
coffee.

1 2

3

4 5

19.

My headache starts after drinking
alcoholic beverages.

1 2

3

4

20 .

I experience car or motion sickness.

1 2

3

4 5

21 .

My headache improves after a period
of rest.

1 2

3

4 5

22.

My headache begins after eating certain kinds of food like n u t s , hot
dogs or chocolate.

1 2

3

4 5

23.

I have sudden attacks of headache.

1 2

3

4 5

24.

My headache is worst at the end of
the working day.

1 2

3

4 5

25.

My headache
ing.

1 2

3

4 5

26.

My headache feels like a tightness
or an external pressure (band-like
or cap-like).

1 2

3

4 5

27.

My headache begins on the left-hand
side of my head.

1 2

3

4 5

during the night

is throbbing or pulsat-

5

84

H

J
W
Dd

<

P5

CO

S
M
H
W
S
O

CO

ALWAYS

fH

Pi

>
W
2

W

hJ
hJ
<1

D
23

CO

28.

My headache begins on the right-hand
side of my head.

1 2

3

4

5

29.

My headache begins in my neck,
shoulders or the back of my head.

1 2

3

4

5

30.

I have nausea and vomiting with my
headaches.

1 2

3

4

5

31.

My headache gets worse if I cough,
strain, or lift objects.

1 2

3

4

5

32.

My headache is better if I can
loosen up my neck m u s c l e s .

1 2

3

4

5

33.

Aspirin, Anacin, Bufferin, Excedrin,
BC, Alka Seltzer, or other nonperscription pain medications r e 
lieve my h e a d a c h e s .

1 2

3

4

5

34.

I take a prescribed medication to
prevent a full blown attack of a
headache.

1 2

3

4

5

35.

My headache begins when I am relaxing or enjoying myself.

1 2

3

4

5

Appendix C

Research Subject's Consent Form

Dr. Donald Williamson, Elise L a b b e ', M.A. and their asso
ciates are conducting a study to determine if temperature
biofeedback and autogenic training will have the effect of
alleviating the pain of migraine headaches in children.
If you agree to let your child participate in this study,
the following requirements will be expected of you and your
child.
First you and your child will be interviewed concerning the
nature of your child's headaches, e.g., symptoms and p o s 
sible causes.
The amount of stress in your child's life
and other problems or situations that may be related to the
headache will be examined.
Based upon information obtained
in the interview, we will ask some persons to participate
in a study to evaluate the extent to which skin temperature
biofeedback procedure reduces headache pain.
The persons who accept our invitation to participate in the
study will be expected to cooperate in the manner described
below: First, each child must obtain written permission
from his/her pediatrician.
For the first four weeks, you
will schedule two meetings with one of the members of our
staff at a time that is mutually agreeable.
During these
meetings physiological measures of facial and arm muscle
tension, finger skin temperature, cephalic blood flow,
heart rate, and galvanic skin response will be recorded.
These measurements will involve placing sensors on the
child's arms, legs, and head to detect the various physio
logical responses.
None of these procedures involve
methods that would be painful or would produce discomfort.
During the first session the child will sit quietly and
will be asked to relax.
During the second session the
child will first be asked to sit quietly and then will a t 
tempt to raise his/her skin temperature.
During this initial month of the study and during the r e 
mainder of the study, children will be expected to record
a rating of their head pain four times daily, i.e., break
fast, lunch, dinner, and bedtime.
After the initial four
weeks of the study, all children will be randomly assigned
either to a group being treated immediately or to a waiting
list group.
For the waiting list group, children will be
asked to wait for 8 weeks before receiving treatment and
will meet three times with our staff to report and discuss
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headache activity.
For the group that receives treatment
immediately, children will be asked to attend two sessions
each week for three weeks and then one session per week for
the next four weeks.
A total of ten treatment sessions
will be required.
In these sessions, a trained therapist
will assist the child in learning skin temperature b i o 
feedback.
Children will also be asked to
practice what
they learn at home.
Participants will be
expected to a t 
tend three follow-up sessions at 1, 3 and 6 months after
the end of therapy.
At any time during the study, you may discuss your child's
progress and ask any questions you may have about the
assessment or therapy procedures.
Also, you may withdraw
your child from the study at any time.
I have read the above information.
I believe I understand
the study sufficiently to participate.
Any questions I
had have been answered to my satisfaction.
I agree to
participate in the study as indicated by signature below.

Signed, Parent
Child
Date
Witness

Appendix D

Medical Consent Form

From: Dr. ________________________________
Date:

I have examined the patient ____________________________
and can see no medical reason that he/she should be unable
to participate in a study to evaluate the effects of
skin temperature biofeedback and relaxation upon migraine
headaches.

Therefore the patient has my permission to

participate in the experiment.

By giving my permission,

I

understand that I am not necessarily endorsing this type
of therapy for headaches and I understand that I am not
legally responsible for the conduct of the therapeutic
methods or the outcome of treatment.

If you have any

questions regarding this study, please feel free to contact
Dr. Donald A. Williamson at the LSU Psychology Department.
(Telephone:

388-8745)

My diagnosis of this patient's headache is: _______________

Signature _________________________
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Appendix E

Potency Rating of Medication
on a Seven-point Scale

1 (Over the counter drugs)
APC
Alka Seltzer
Anacin
Aspirin
Bufferin
Ceclar
Comtrex
Cope
Datril
Empirin
Excedrin
Midrin

Nervine
Norgesic
Parafon
Percogesics
Persistin
Phenaphen
Robaxisal
Sinutab
Sudafed
Synalgos
Tylenol 1 & 2
Vanquish

(Sedatives)
Darvon
Dilantin
Fiornal
Inderal
Librium
Mepergan (fortis)

Periactn
Pherergan
Seconal
Triavil
Valium
Vistaril

(Vasoconstrictors)
Bellegal
Cafergot (Cafregon)
Ergotrate

Ergostat
Gynergen

(Analgesics)
Codeine
or other medication with codeine
examples: Emperin, Mepergan,
Percogesics, Phenergan and
Tylenol 3 s & 4 s .
Leratine
Ponstel
Talwin
5 Demerol
6 Dilaudid
7 Morphine
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